Idel raises $10.4M for intracellular pan-cancer drug delivery tech
Newco Idel Therapeutics GmbH has closed a €9 million (US$10.4 million) seed round to advance the development of a technology for delivery of cytotoxic drugs directly into the cytosol of tumor cells, opening up previously undruggable intracellular targets.
NM
nuala moran
via Bioworld
Updated 2h ago

Source Verification
Corroboration Score: 1This story was independently reported by 1 sources. Click any source to read the original article.
Comments
0 commentsBe respectful and constructive.
Loading comments...
Previous
Your brain reacts to nature in ways scientists can now measure
Next
Labyrinth Anime Movie Gets New Trailer & Poster
Related Articles
Science
Science
Science
People with ADHD could be going undiagnosed as Wollongong research reveals gaps
Illawarra Mercury-12h ago-1 sources
ScienceWhy your psoriasis flares up in the same spots
Scientificamerican-12h ago-1 sources
ScienceSperm whales help one another give birth, new study finds
Scientificamerican-12h ago-1 sources